PHOR.ME
Public Joint-Stock Company PhosAgro [PHOR.ME] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PHOR.ME Stock Summary
In the News
PHOR.ME Financial details
Company Rating
Strong Buy
Market Cap
1026.81B
Income
169.25B
Revenue
505.03B
Book val./share
1277.21
Cash/share
558.75
Dividend
1488
Dividend %
18.77%
Employees
25K
Optionable
No
Shortable
Yes
Earnings
03 Aug 2023
P/E
6.07
Forward P/E
10.79
PEG
-1.21
P/S
2.03
P/B
6.21
P/C
14.19
P/FCF
6.94
Quick Ratio
0.36
Current Ratio
0.92
Debt / Equity
2.06
LT Debt / Equity
0.75
-
-
EPS (TTM)
499
EPS next Y
734.74
EPS next Q
-
EPS this Y
42.32%
EPS next Y
47.24%
EPS next 5Y
47.24%
EPS last 5Y
53.02%
Revenue last 5Y
19.53%
Revenue Q/Q
5.52%
EPS Q/Q
-
-
-
-
-
SMA20
6.38%
SMA50
6.01%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
33%
ROE
78%
ROC
0.74%
Gross Margin
49%
Oper. Margin
45%
Profit Margin
34%
Payout
-
Shs Outstand
129.5M
Shs Float
46.15M
-
-
-
-
Target Price
-
52W Range
3700.0-10097.0
52W High
-21.47%
52W Low
+114.3%
RSI
43
Rel Volume
-
Avg Volume
-
Volume
26.99K
Perf Week
16.09%
Perf Month
25.86%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.024523
-
-
Volatility
496.04%, 311.62%
Prev Close
23.79%
Price
7929
Change
23.56%
PHOR.ME Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 1.8K | 1.92K | 1.96K | 3.25K | 4.4K | |
| Net income per share | 170 | 381.07 | 130.75 | 1K | 1.43K | |
| Operating cash flow per share | 459.71 | 552.56 | 646.63 | 974.71 | 1.57K | |
| Free cash flow per share | 163.79 | 223.17 | 330.97 | 604.43 | 1.08K | |
| Cash per share | 72.04 | 65.54 | 67.73 | 169.31 | 103.14 | |
| Book value per share | 844.46 | 968.86 | 815.58 | 1.27K | 1.53K | |
| Tangible book value per share | 845.96 | 970.17 | 816.57 | 1.27K | 1.53K | |
| Share holders equity per share | 844.46 | 968.86 | 815.58 | 1.27K | 1.53K | |
| Interest debt per share | 1.15K | 1.11K | 1.32K | 1.39K | 1.53K | |
| Market cap | 329.09B | 311.84B | 406.63B | 759.39B | 1026.94B | |
| Enterprise value | 464.42B | 443.42B | 563.51B | 913.11B | 1207.27B | |
| P/E ratio | 14.91 | 6.32 | 24.02 | 5.86 | 5.56 | |
| Price to sales ratio | 1.41 | 1.26 | 1.6 | 1.81 | 1.8 | |
| POCF ratio | 5.51 | 4.36 | 4.86 | 6.02 | 5.05 | |
| PFCF ratio | 15.48 | 10.79 | 9.49 | 9.7 | 7.37 | |
| P/B Ratio | 3 | 2.49 | 3.85 | 4.62 | 5.2 | |
| PTB ratio | 3 | 2.49 | 3.85 | 4.62 | 5.2 | |
| EV to sales | 1.99 | 1.79 | 2.22 | 2.17 | 2.12 | |
| Enterprise value over EBITDA | 8.66 | 4.96 | 9.36 | 4.75 | 4.46 | |
| EV to operating cash flow | 7.78 | 6.2 | 6.73 | 7.23 | 5.94 | |
| EV to free cash flow | 21.84 | 15.34 | 13.15 | 11.67 | 8.66 | |
| Earnings yield | 0.07 | 0.16 | 0.04 | 0.17 | 0.18 | |
| Free cash flow yield | 0.06 | 0.09 | 0.11 | 0.1 | 0.14 | |
| Debt to equity | 1.61 | 1.41 | 2.05 | 1.46 | 1.31 | |
| Debt to assets | 0.62 | 0.58 | 0.67 | 0.59 | 0.57 | |
| Net debt to EBITDA | 2.52 | 1.47 | 2.61 | 0.8 | 0.67 | |
| Current ratio | 1.79 | 1.07 | 0.77 | 1.92 | 1.11 | |
| Interest coverage | 11.58 | 12.09 | 6.15 | 32.54 | 50.48 | |
| Income quality | 2.7 | 1.39 | 1.45 | 0.77 | 0.89 | |
| Dividend Yield | 0.04 | 0.1 | 0.1 | 0.1 | 0.14 | |
| Payout ratio | 0.62 | 0.65 | 2.29 | 0.56 | 0.77 | |
| Sales general and administrative to revenue | 0.02 | 0.07 | 0.02 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.01 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | -0.64 | -0.6 | -0.49 | -0.38 | -0.31 | |
| Capex to revenue | -0.16 | -0.17 | -0.16 | -0.11 | -0.11 | |
| Capex to depreciation | -1.84 | -1.78 | -1.54 | -1.73 | -2.16 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.8K | 2.88K | 1.55K | 5.35K | 7K | |
| ROIC | 0.16 | 0.16 | 0.08 | 0.42 | 0.44 | |
| Return on tangible assets | 0.08 | 0.16 | 0.05 | 0.32 | 0.41 | |
| Graham Net | -1.16K | -1.19K | -1.48K | -1.53K | -1.74K | |
| Working capital | 34.19B | 4.54B | -22.1B | 60.81B | 13.74B | |
| Tangible asset value | 109.82B | 124.07B | 104.13B | 162.89B | 195.62B | |
| Net current asset value | -98.71B | -108.03B | -142.33B | -113.62B | -116.58B | |
| Invested capital | 1.32 | 1.11 | 1.57 | 1.07 | 0.98 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 6.98B | 16.85B | 32.59B | 40.45B | 28.73B | |
| Average inventory | 29.61B | 30.64B | 31.02B | 36.91B | 40.26B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 22.6 | 69.75 | 107.18 | 69.65 | 21.3 | |
| Days of inventory on hand | 93.84 | 78.79 | 89.34 | 68.69 | 53.39 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 16.15 | 5.23 | 3.41 | 5.24 | 17.13 | |
| Inventory turnover | 3.89 | 4.63 | 4.09 | 5.31 | 6.84 | |
| ROE | 0.2 | 0.39 | 0.16 | 0.79 | 0.93 | |
| Capex per share | -295.92 | -329.39 | -315.66 | -370.28 | -493.21 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 1.4K | 0 | 949.14 | 0 | 897.13 | |
| Net income per share | 335.64 | 0 | 281.47 | 0 | 216.64 | |
| Operating cash flow per share | 351 | 0 | 407.95 | 0 | 416.24 | |
| Free cash flow per share | 269.37 | 0 | 303.12 | 0 | 335.19 | |
| Cash per share | 0 | 0 | 825.71 | 0 | 558.75 | |
| Book value per share | 0 | 0 | 1.7K | 0 | 1.28K | |
| Tangible book value per share | 0 | 0 | 1.7K | 0 | 1.28K | |
| Share holders equity per share | 0 | 0 | 1.7K | 0 | 1.28K | |
| Interest debt per share | 0 | 0 | 1.1K | 0 | 1.67K | |
| Market cap | 1041.83B | 0 | 1026.94B | 0 | 1026.94B | |
| Enterprise value | 0 | 62.08B | 1060.85B | 180.34B | 1169.37B | |
| P/E ratio | 5.99 | 0 | 7.04 | 0 | 9.15 | |
| Price to sales ratio | 5.77 | 0 | 8.35 | 0 | 8.84 | |
| POCF ratio | 22.92 | 0 | 19.44 | 0 | 19.05 | |
| PFCF ratio | 29.87 | 0 | 26.16 | 0 | 23.66 | |
| P/B Ratio | 0 | 0 | 4.67 | 0 | 6.21 | |
| PTB ratio | 0 | 0 | 4.67 | 0 | 6.21 | |
| EV to sales | 0 | 0.4 | 8.63 | 1.64 | 10.07 | |
| Enterprise value over EBITDA | 0 | 0.53 | 19.82 | 5.57 | 26.79 | |
| EV to operating cash flow | 0 | 1.02 | 20.08 | 4.11 | 21.69 | |
| EV to free cash flow | 0 | 1.45 | 27.03 | 8.04 | 26.94 | |
| Earnings yield | 0.04 | 0 | 0.04 | 0 | 0.03 | |
| Free cash flow yield | 0.03 | 0 | 0.04 | 0 | 0.04 | |
| Debt to equity | 0 | 0.67 | 1.37 | 1.31 | 2.06 | |
| Debt to assets | 0 | 0.4 | 0.58 | 0.57 | 0.67 | |
| Net debt to EBITDA | 0 | 0.53 | 0.63 | 5.57 | 3.26 | |
| Current ratio | 0 | 2.2 | 1.22 | 1.11 | 0.92 | |
| Interest coverage | 48.83 | 105.57 | 52.81 | 21.77 | 22.38 | |
| Income quality | 0.57 | 1.53 | 0.93 | 0.85 | 1.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.23 | -0.3 | -0.26 | -0.49 | -0.19 | |
| Capex to revenue | -0.06 | -0.12 | -0.11 | -0.19 | -0.09 | |
| Capex to depreciation | -1.43 | -2.29 | -1.87 | -3.11 | -1.34 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 3.28K | 0 | 2.5K | |
| ROIC | 0 | 0.27 | 0.15 | 0.05 | 0.08 | |
| Return on tangible assets | 0 | 0.18 | 0.07 | 0.04 | 0.06 | |
| Graham Net | 0 | 0 | -1.36K | 0 | -1.93K | |
| Working capital | 0 | 101.11B | 40.12B | 13.74B | -16.13B | |
| Tangible asset value | 0 | 282.75B | 218.2B | 195.62B | 163.45B | |
| Net current asset value | 0 | -4.4B | -77.92B | -116.58B | -155.16B | |
| Invested capital | 0 | 0.47 | 0.64 | 0.98 | 1.3 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 7.97B | 11.76B | 15.1B | |
| Average inventory | 0 | 0 | 35.31B | 38.02B | 38.7B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 9.73 | 11.29 | 25.4 | 20.29 | |
| Days of inventory on hand | 0 | 40.69 | 53.03 | 63.66 | 53.24 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 9.25 | 7.97 | 3.54 | 4.43 | |
| Inventory turnover | 0 | 2.21 | 1.7 | 1.41 | 1.69 | |
| ROE | 0 | 0.3 | 0.17 | 0.1 | 0.17 | |
| Capex per share | -81.63 | 0 | -104.83 | 0 | -81.05 |
PHOR.ME Frequently Asked Questions
What is Public Joint-Stock Company PhosAgro stock symbol ?
Public Joint-Stock Company PhosAgro is a RU stock and trading under the symbol PHOR.ME
What is Public Joint-Stock Company PhosAgro stock quote today ?
Public Joint-Stock Company PhosAgro stock price is $7929 today.
Is Public Joint-Stock Company PhosAgro stock public?
Yes, Public Joint-Stock Company PhosAgro is a publicly traded company.
Company Profile
- Market Capitalization 1026.81B
- Employee 25K
- CEO Mr. Mikhail Konstantinovich Rybnikov
- Headquarters Moscow,RU
- IPO Date 2012-03-26
-
Website
https://www.phosagro.com 
Public Joint-Stock Company PhosAgro, together with its subsidiaries, engages in the production and distribution of apatite concentrate and mineral fertilizers in Russia and internationally. It operates in two segments, Phosphate-Based Products and Nitrogen-Based Products. The Phosphate-Based Products segment produces and distributes ammophos, diammoniumphosphate, sodium tripolyphosphate, and other phosphate based and complex fertilizers; and apatite concentrate extracted from the apatite-nepheline ore. The Nitrogen-Based Products segment is involved in the production and distribution of ammonia, ammonium nitrate, and urea. It also offers feed phosphates; phosphate rock; and industrial products, such as syenite alkali aluminum concentrate, titanomagnetite concentrate, nepheline concentrate, aegirine concentrate, oleum, sulphuric acid, sodiumsilicofluoride, aluminum fluoride, nitric acid, and ammonia solution. Public Joint-Stock Company PhosAgro was incorporated in 2001 and is headquartered in Moscow, the Russian Federation.
